TY  - JOUR 
AU  - Mateos Manteca, María Victoria
AU  - Cavo, Michele
AU  - Bladé, Joan
AU  - Dimopoulos, Meletios A.
AU  - Suzuki, Kenshi
AU  - Jakubowiak, Andrzej
AU  - Knop, Stefan
AU  - Doyen, Chantal
AU  - Lucio, Paulo
AU  - Nagy, Zsolt
AU  - Pour, Ludek
AU  - Cook, Mark
AU  - Grosicki, Sebastian
AU  - Crepaldi, Andre
AU  - Liberati, Anna Marina
AU  - Campbell, Philip
AU  - Shelekhova, Tatiana
AU  - Yoon, Sung-Soo
AU  - Iosava, Genadi
AU  - Fujisaki, Tomoaki
AU  - Garg, Mamta
AU  - Krevvata, Maria
AU  - Chen, Ying
AU  - Wang, Jianping
AU  - Kudva, Anupa
AU  - Ukropec, Jon
AU  - Wroblewski, Susan
AU  - Qi, Ming
AU  - Kobos, Rachel
AU  - San Miguel Izquierdo, Jesús Fernando
PY  - 2020
SN  - 0140-6736
UR  - http://hdl.handle.net/10366/154487
AB  - [EN]Standard-of-care treatment for patients with newly diagnosed multiple myeloma includes combination
therapies for patients who are not eligible for autologous stem-cell transplantation. At the primary analysis for
progression-free survival of the...
LA  - eng
PB  - Elsevier
KW  - Mieloma múltiple
KW  - Multiple Myeloma
TI  - Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
DO  - 10.1016/S0140-6736(19)32956-3
T2  - The Lancet
VL  - 395
M2  - 132
ER  -